4//SEC Filing
Ozden Rabia Gurses 4
Accession 0001415889-24-017681
CIK 0001501756other
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 4:50 PM ET
Size
12.6 KB
Accession
0001415889-24-017681
Insider Transaction Report
Form 4
Ozden Rabia Gurses
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-06-17+85,000→ 85,000 totalExercise: $7.32Exp: 2034-06-16→ Common Stock (85,000 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the total number of shares subject to the option shall vest and become exercisable on the first anniversary of June 10, 2024 (the "Vesting Commencement Date"), and one-forty-eighth (1/48th) of the total number of shares subject to the option shall vest and become exercisable each month thereafter, such that all of the shares subject to the option shall become vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service with the Issuer on each such vesting date.
Documents
Issuer
Adverum Biotechnologies, Inc.
CIK 0001501756
Entity typeother
Related Parties
1- filerCIK 0001814883
Filing Metadata
- Form type
- 4
- Filed
- Jun 19, 8:00 PM ET
- Accepted
- Jun 20, 4:50 PM ET
- Size
- 12.6 KB